Association between different anticholinergic drugs and subsequent dementia risk in patients with diabetes mellitus

BACKGROUND: The effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with diabetes mellitus (DM) remain unknown. We investigated the effects of oxybutynin, solifenacin and tolterodine on dementia risk in patients with DM. METHODS: We conducted a cohort study by using the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yu-Wan, Liu, Hsin-Ho, Lin, Tien-Huang, Chuang, Hsun-Yang, Hsieh, Tengfu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383287/
https://www.ncbi.nlm.nih.gov/pubmed/28384267
http://dx.doi.org/10.1371/journal.pone.0175335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383287/
https://www.ncbi.nlm.nih.gov/pubmed/28384267
http://dx.doi.org/10.1371/journal.pone.0175335

Ejemplares similares